Literature DB >> 26756763

Targeted Nanotherapies for the Treatment of Surgical Diseases.

Courtney E Morgan1, Molly A Wasserman, Melina R Kibbe.   

Abstract

OBJECTIVE: To describe the components of targeted nanotherapeutics and to review their applications in the treatment of surgical diseases.
BACKGROUND: Targeted nanotherapeutic is a novel strategy for treating a variety of diseases and is an emerging technology that offers advantages over current treatment strategies. The nanoscale size, combined with the ability to surface functionalize the delivery vehicle to enable targeting and incorporate a therapeutic payload, provides a new and innovative therapeutic platform to treat surgical diseases that has yet to be fully realized in the surgical arena.
METHODS: A comprehensive literature review of nanotherapeutics, targeting strategies, and their utility in treating surgical diseases is performed.
RESULTS: Targeted nanotherapeutics have demonstrated safety and biocompatibility in treating surgical diseases. The ability to surface functionalize the nanoparticles affords a unique tailorability that enables targeting specificity and therapeutic payload delivery to treat a variety of surgical diseases. Moreover, the small size and targeting capabilities allow access to biological compartments, such as the blood-brain barrier, that have previously been difficult to treat.
CONCLUSIONS: Targeted nanotherapeutics represent a novel therapeutic platform and have great potential to impact the treatment of surgical diseases.

Entities:  

Mesh:

Year:  2016        PMID: 26756763      PMCID: PMC5142627          DOI: 10.1097/SLA.0000000000001605

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  62 in total

1.  Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.

Authors:  Amir Fakhari; Abdulgader Baoum; Teruna J Siahaan; Khoi Ba Le; Cory Berkland
Journal:  J Pharm Sci       Date:  2010-10-04       Impact factor: 3.534

2.  A tissue factor targeted nanomedical system for thrombi-specific drug delivery.

Authors:  Wei Shi; Heng Mei; Jun Deng; Chen Chen; Huafang Wang; Tao Guo; Bo Zhang; Le Li; Zhiqing Pang; Xinguo Jiang; Shun Shen; Yu Hu
Journal:  Biomaterials       Date:  2012-07-21       Impact factor: 12.479

3.  Biomimetic amplification of nanoparticle homing to tumors.

Authors:  Dmitri Simberg; Tasmia Duza; Ji Ho Park; Markus Essler; Jan Pilch; Lianglin Zhang; Austin M Derfus; Meng Yang; Robert M Hoffman; Sangeeta Bhatia; Michael J Sailor; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-10       Impact factor: 11.205

4.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

Authors:  Jolanta F Kukowska-Latallo; Kimberly A Candido; Zhengyi Cao; Shraddha S Nigavekar; Istvan J Majoros; Thommey P Thomas; Lajos P Balogh; Mohamed K Khan; James R Baker
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

5.  Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods.

Authors:  Abhiruchi Agarwal; Megan A Mackey; Mostafa A El-Sayed; Ravi V Bellamkonda
Journal:  ACS Nano       Date:  2011-06-02       Impact factor: 15.881

6.  Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake.

Authors:  H Carrstensen; R H Müller; B W Müller
Journal:  Clin Nutr       Date:  1992-10       Impact factor: 7.324

Review 7.  Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability.

Authors:  Daniele Venturoli; Bengt Rippe
Journal:  Am J Physiol Renal Physiol       Date:  2005-04

8.  Spontaneous isolated dissection of the celiac trunk with rupture of the proximal splenic artery: a case report.

Authors:  J Nordanstig; H Gerdes; E Kocys
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-11-17       Impact factor: 7.069

Review 9.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

Review 10.  Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.

Authors:  B Mishra; Bhavesh B Patel; Sanjay Tiwari
Journal:  Nanomedicine       Date:  2009-05-15       Impact factor: 5.307

View more
  7 in total

1.  Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery.

Authors:  Erica B Peters; Nick D Tsihlis; Mark R Karver; Stacey M Chin; Bruno Musetti; Benjamin T Ledford; Edward M Bahnson; Samuel I Stupp; Melina R Kibbe
Journal:  Adv Healthc Mater       Date:  2019-01-08       Impact factor: 9.933

Review 2.  Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery.

Authors:  Mirnal A Chaudhary; Lian-Wang Guo; Xudong Shi; Guojun Chen; Shaoqin Gong; Bo Liu; K Craig Kent
Journal:  J Control Release       Date:  2016-05-12       Impact factor: 9.776

3.  Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis.

Authors:  Neel A Mansukhani; Erica B Peters; Miranda M So; Mazen S Albaghdadi; Zheng Wang; Mark R Karver; Tristan D Clemons; Jeffrey P Laux; Nick D Tsihlis; Samuel I Stupp; Melina R Kibbe
Journal:  Macromol Biosci       Date:  2019-05-08       Impact factor: 4.979

Review 4.  Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.

Authors:  Janel Kydd; Rahul Jadia; Praveena Velpurisiva; Aniket Gad; Shailee Paliwal; Prakash Rai
Journal:  Pharmaceutics       Date:  2017-10-14       Impact factor: 6.321

5.  Systemically administered collagen-targeted gold nanoparticles bind to arterial injury following vascular interventions.

Authors:  Molly Wasserman Meyers; Jonathan S Rink; Qun Jiang; Megan E Kelly; Janet M Vercammen; Colby S Thaxton; Melina R Kibbe
Journal:  Physiol Rep       Date:  2017-02-27

Review 6.  Systemically Administered, Target-Specific, Multi-Functional Therapeutic Recombinant Proteins in Regenerative Medicine.

Authors:  Tero A H Järvinen; Toini Pemmari
Journal:  Nanomaterials (Basel)       Date:  2020-01-28       Impact factor: 5.076

Review 7.  Chitosan-Based Nanomaterials for Drug Delivery.

Authors:  Jianghua Li; Chao Cai; Jiarui Li; Jun Li; Jia Li; Tiantian Sun; Lihao Wang; Haotian Wu; Guangli Yu
Journal:  Molecules       Date:  2018-10-16       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.